Clinical Trials Directory

Trials / Terminated

TerminatedNCT03255798

A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra

A Prospective Evaluation of Mild to Moderate Open-Angle Glaucoma Subjects Treated With Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Glaukos Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective Evaluation of Open-Angle Glaucoma Subjects treated with two second generation iStents and one iStent Supra

Detailed description

Prospective Evaluation of Mild to Moderate Open-Angle Glaucoma Subjects treated with Two Second Generation Microbypass Stents and One Suprachoroidal Stent

Conditions

Interventions

TypeNameDescription
DEVICEG2 and G3Two iStent inject devices and one iStent supra device

Timeline

Start date
2017-08-01
Primary completion
2019-06-06
Completion
2019-06-06
First posted
2017-08-21
Last updated
2022-09-09

Locations

1 site across 1 country: Germany

Regulatory

Source: ClinicalTrials.gov record NCT03255798. Inclusion in this directory is not an endorsement.

A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra (NCT03255798) · Clinical Trials Directory